Neuroprotective Effects of Black Pepper Cold-Pressed Oil on Scopolamine-Induced Oxidative Stress and Memory Impairment in Rats

被引:36
|
作者
Mostafa, Nada M. [1 ]
Mostafa, Ahmed M. [2 ]
Ashour, Mohamed L. [1 ,3 ]
Elhady, Sameh S. [4 ]
机构
[1] Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Cairo 11566, Egypt
[2] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo 11566, Egypt
[3] Batterjee Med Coll, Pharm Program, Dept Pharmaceut Sci, Jeddah 21442, Saudi Arabia
[4] King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21589, Saudi Arabia
关键词
black pepper; cold-pressed oil; GC-MS; neuroprotective; scopolamine; PIPER-NIGRUM L; BETA-CARYOPHYLLENE; ANTIOXIDANT; EXTRACT; LIVER; DEFICITS; SESAMIN; PROFILE; LEAVES; PLANTS;
D O I
10.3390/antiox10121993
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is usually associated with many neurodegenerative diseases. In this study, the gas chromatography-mass spectrometry (GC-MS) analysis of cold-pressed oil (CPO) from black pepper (Piper nigrum) fruits was performed and its neuroprotective effects were evaluated for the first time. The analysis of CPO revealed the presence of the lignan sesamin (39.78%), the alkaloid piperine (33.79%), the monoterpene hydrocarbons 3-carene (9.53%) and limonene (6.23%), and the sesquiterpene beta-caryophyllene (10.67%). Black pepper hydrodistilled oil (HDO) was also comparatively analyzed by GC-MS to show the impact of oil isolation by two different methodologies on their components and class of compounds identified. HDO analysis revealed 35 compounds (99.64% of the total peak areas) mainly composed of monoterpene hydrocarbons (77.28%), such as limonene (26.50%), sabinene (21.36%), and beta-pinene (15.53%), and sesquiterpene hydrocarbons (20.59%) represented mainly by beta-caryophyllene (19.12%). Due to the low yield obtained for HDO (0.01% v/w), only CPO was chosen for the evaluation of its neuroprotective potential. Alzheimer-type dementia was induced in rats by scopolamine intraperitoneal injection (1.5 mg/kg/day) for seven days. CPO was administered orally (100 mg/kg) for a week before scopolamine administration and then concomitantly for another week. Donepezil (1 mg/kg, orally) was used as a reference drug. CPO administration significantly improved the rat behaviors as evaluated by the Morris water maze test, evident from prolongation in time spent in the platform quadrant (262.9%, compared to scopolamine) and increasing in the crossing time by 18.18% compared to the control group. The rat behavior tested by passive avoidance, showed prolongation in the step-through latency compared to control. Moreover, CPO significantly (p < 0.05) ameliorated the activities of antioxidant enzymes such as catalase, superoxide dismutase (SOD) and reduced malondialdehyde (MDA) equivalents by 22.48%, 45.41%, and 86.61%, respectively, compared to scopolamine. Furthermore, CPO administration decreased scopolamine-induced elevated acetylcholinesterase levels in rats' hippocampi by 51.30%. These results were supported by histopathological and in silico molecular docking studies. Black pepper oil may be a potential antioxidant and neuroprotective supplement.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
    Anoush, Mahdieh
    Taghaddosi, Neda
    Hosseini, Zahra Bokaei
    Rahmati, Fatemeh
    Bijani, Soroush
    Kalantari-Hesari, Ali
    Hosseini, Mir-Jamal
    IBRO NEUROSCIENCE REPORTS, 2025, 18 : 163 - 170
  • [2] NEUROPROTECTIVE EFFECT OF RESVERATROL AGAINST SCOPOLAMINE-INDUCED COGNITIVE IMPAIRMENT AND OXIDATIVE STRESS IN RATS
    Pushpalatha, Bunadri
    Venumadhav, Neerati
    Swathi, Merugu
    Raju, Akondi Butchi
    ARCHIVES OF BIOLOGICAL SCIENCES, 2013, 65 (04) : 1381 - 1386
  • [3] Neuroprotective Effects of Citrus reticulata in Scopolamine-Induced Dementia Oxidative Stress in Rats
    El-Khadragy, Manal F.
    Al-Olayan, Ebtesam M.
    Moneim, Ahmed E. Abdel
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (04) : 684 - 690
  • [4] Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats
    Hafez, Hani S.
    Ghareeb, Doaa A.
    Saleh, Samar R.
    Abady, Mariam M.
    El Demellawy, Maha A.
    Hussien, Hend
    Abdel-Monem, Nihad
    PSYCHOPHARMACOLOGY, 2017, 234 (20) : 3037 - 3053
  • [5] Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats
    Hani S. Hafez
    Doaa A. Ghareeb
    Samar R. Saleh
    Mariam M. Abady
    Maha A. El Demellawy
    Hend Hussien
    Nihad Abdel-Monem
    Psychopharmacology, 2017, 234 : 3037 - 3053
  • [6] Effects of Vitexin on Scopolamine-Induced Memory Impairment in Rats
    Abbasi, Esmail
    Nassiri-Asl, Marjan
    Sheikhi, Mehdi
    Shafiee, Mahsa
    CHINESE JOURNAL OF PHYSIOLOGY, 2013, 56 (03): : 184 - 189
  • [7] Barbigerone prevents scopolamine-induced memory impairment in rats by inhibiting oxidative stress and acetylcholinesterase levels
    AlGhamdi, Shareefa A.
    Al-Abbasi, Fahad A.
    Alghamdi, Amira M.
    Omer, Asma B.
    Afzal, Obaid
    Altamimi, Abdulmalik S. A.
    Alamri, Abdulaziz
    Alzarea, Sami I.
    Almalki, Waleed Hassan
    Kazmi, Imran
    ROYAL SOCIETY OPEN SCIENCE, 2023, 10 (04):
  • [8] Neuroprotective effects of Indole 3-carbinol against Scopolamine-Induced cognitive and memory impairment in rats: modulation of oxidative stress, inflammatory and cholinergic pathways
    Vinjavarapu, Laksmi Anusha
    Yadava, Srikanth
    Dontiboina, Harikrishna Reddy
    Chakravarthi, Guntupalli
    Kakarla, Ramakrishna
    METABOLIC BRAIN DISEASE, 2025, 40 (04)
  • [9] Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice
    Barbara Budzynska
    Anna Boguszewska-Czubara
    Marta Kruk-Slomka
    Krystyna Skalicka-Wozniak
    Agnieszka Michalak
    Irena Musik
    Grazyna Biala
    Psychopharmacology, 2015, 232 : 931 - 942
  • [10] Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice
    Budzynska, Barbara
    Boguszewska-Czubara, Anna
    Kruk-Slomka, Marta
    Skalicka-Wozniak, Krystyna
    Michalak, Agnieszka
    Musik, Irena
    Biala, Grazyna
    PSYCHOPHARMACOLOGY, 2015, 232 (05) : 931 - 942